Cargando…

Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia

INTRODUCTION: Zambia experienced a major cholera outbreak in 2017–2018, with more than 5905 cases reported countrywide, predominantly from the peri-urban slums of Lusaka city. The WHO recommends the use of oral cholera vaccines (OCVs) together with traditional control measures, including health prom...

Descripción completa

Detalles Bibliográficos
Autores principales: Sialubanje, Cephas, Kapina, Muzala, Chewe, Orbrie, Matapo, Belem Blamwell, Ngomah, Albertina Moraes, Gianetti, Brittany, Ngosa, William, Kasonde, Mpanga, Musonda, Kunda, Mulenga, Modest, Michelo, C, Sinyange, Nyambe, Bobo, Patricia, Zyambo, Khozya, Mazyanga, Lucy, Bakyaita, Nathan, Mukonka, Victor M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660660/
https://www.ncbi.nlm.nih.gov/pubmed/36368745
http://dx.doi.org/10.1136/bmjopen-2022-066945
_version_ 1784830432611663872
author Sialubanje, Cephas
Kapina, Muzala
Chewe, Orbrie
Matapo, Belem Blamwell
Ngomah, Albertina Moraes
Gianetti, Brittany
Ngosa, William
Kasonde, Mpanga
Musonda, Kunda
Mulenga, Modest
Michelo, C
Sinyange, Nyambe
Bobo, Patricia
Zyambo, Khozya
Mazyanga, Lucy
Bakyaita, Nathan
Mukonka, Victor M
author_facet Sialubanje, Cephas
Kapina, Muzala
Chewe, Orbrie
Matapo, Belem Blamwell
Ngomah, Albertina Moraes
Gianetti, Brittany
Ngosa, William
Kasonde, Mpanga
Musonda, Kunda
Mulenga, Modest
Michelo, C
Sinyange, Nyambe
Bobo, Patricia
Zyambo, Khozya
Mazyanga, Lucy
Bakyaita, Nathan
Mukonka, Victor M
author_sort Sialubanje, Cephas
collection PubMed
description INTRODUCTION: Zambia experienced a major cholera outbreak in 2017–2018, with more than 5905 cases reported countrywide, predominantly from the peri-urban slums of Lusaka city. The WHO recommends the use of oral cholera vaccines (OCVs) together with traditional control measures, including health promotion, provision of safe water and improving sanitation, in cholera endemic areas and during cholera outbreaks. In response to this outbreak, the Zambian government implemented the OVC campaign and administered the Euvichol-plus vaccine in the high-risk subdistricts of Lusaka. Although OCVs have been shown to be effective in preventing cholera infection in cholera endemic and outbreak settings, the effectiveness of the Euvichol-plus vaccine has not yet been evaluated in Zambia. This study aimed to determine the effectiveness of two doses of OCV administered during the 2017/2018 vaccination campaign. METHODS: We conducted a matched case–control study involving 79 cases and 316 controls following the mass vaccination campaign in the four subdistricts of Lusaka (Chawama, Chipata, Kanyama and Matero). Matching of controls was based on the place of residence, age and sex. Conditional logistic regression was used for analysis. Adjusted OR (AOR), 95% CI and vaccine effectiveness (1-AOR) for two doses of Euvichol-plus vaccine and any dose were estimated (p<0.05). RESULTS: The AOR vaccine effectiveness for two doses of Euvichol-plus OCV was 81.0% (95% CI 66.0% to 78.0%; p<0.01). Secondary analysis showed that vaccine effectiveness for any dose was 74.0% (95% CI 50.0% to 86.0%; p<0.01). CONCLUSION: These findings show that two doses of Euvichol-plus OCV are effective in a cholera outbreak setting in Lusaka, Zambia. The findings also indicate that two doses are more effective than a single dose and thus support the use of two doses of the vaccine as part of an integrated intervention to cholera control during outbreaks.
format Online
Article
Text
id pubmed-9660660
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96606602022-11-15 Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia Sialubanje, Cephas Kapina, Muzala Chewe, Orbrie Matapo, Belem Blamwell Ngomah, Albertina Moraes Gianetti, Brittany Ngosa, William Kasonde, Mpanga Musonda, Kunda Mulenga, Modest Michelo, C Sinyange, Nyambe Bobo, Patricia Zyambo, Khozya Mazyanga, Lucy Bakyaita, Nathan Mukonka, Victor M BMJ Open Epidemiology INTRODUCTION: Zambia experienced a major cholera outbreak in 2017–2018, with more than 5905 cases reported countrywide, predominantly from the peri-urban slums of Lusaka city. The WHO recommends the use of oral cholera vaccines (OCVs) together with traditional control measures, including health promotion, provision of safe water and improving sanitation, in cholera endemic areas and during cholera outbreaks. In response to this outbreak, the Zambian government implemented the OVC campaign and administered the Euvichol-plus vaccine in the high-risk subdistricts of Lusaka. Although OCVs have been shown to be effective in preventing cholera infection in cholera endemic and outbreak settings, the effectiveness of the Euvichol-plus vaccine has not yet been evaluated in Zambia. This study aimed to determine the effectiveness of two doses of OCV administered during the 2017/2018 vaccination campaign. METHODS: We conducted a matched case–control study involving 79 cases and 316 controls following the mass vaccination campaign in the four subdistricts of Lusaka (Chawama, Chipata, Kanyama and Matero). Matching of controls was based on the place of residence, age and sex. Conditional logistic regression was used for analysis. Adjusted OR (AOR), 95% CI and vaccine effectiveness (1-AOR) for two doses of Euvichol-plus vaccine and any dose were estimated (p<0.05). RESULTS: The AOR vaccine effectiveness for two doses of Euvichol-plus OCV was 81.0% (95% CI 66.0% to 78.0%; p<0.01). Secondary analysis showed that vaccine effectiveness for any dose was 74.0% (95% CI 50.0% to 86.0%; p<0.01). CONCLUSION: These findings show that two doses of Euvichol-plus OCV are effective in a cholera outbreak setting in Lusaka, Zambia. The findings also indicate that two doses are more effective than a single dose and thus support the use of two doses of the vaccine as part of an integrated intervention to cholera control during outbreaks. BMJ Publishing Group 2022-11-11 /pmc/articles/PMC9660660/ /pubmed/36368745 http://dx.doi.org/10.1136/bmjopen-2022-066945 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Sialubanje, Cephas
Kapina, Muzala
Chewe, Orbrie
Matapo, Belem Blamwell
Ngomah, Albertina Moraes
Gianetti, Brittany
Ngosa, William
Kasonde, Mpanga
Musonda, Kunda
Mulenga, Modest
Michelo, C
Sinyange, Nyambe
Bobo, Patricia
Zyambo, Khozya
Mazyanga, Lucy
Bakyaita, Nathan
Mukonka, Victor M
Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia
title Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia
title_full Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia
title_fullStr Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia
title_full_unstemmed Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia
title_short Effectiveness of two doses of Euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in Lusaka, Zambia
title_sort effectiveness of two doses of euvichol-plus oral cholera vaccine in response to the 2017/2018 outbreak: a matched case–control study in lusaka, zambia
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9660660/
https://www.ncbi.nlm.nih.gov/pubmed/36368745
http://dx.doi.org/10.1136/bmjopen-2022-066945
work_keys_str_mv AT sialubanjecephas effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT kapinamuzala effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT cheweorbrie effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT matapobelemblamwell effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT ngomahalbertinamoraes effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT gianettibrittany effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT ngosawilliam effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT kasondempanga effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT musondakunda effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT mulengamodest effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT micheloc effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT sinyangenyambe effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT bobopatricia effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT zyambokhozya effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT mazyangalucy effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT bakyaitanathan effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia
AT mukonkavictorm effectivenessoftwodosesofeuvicholplusoralcholeravaccineinresponsetothe20172018outbreakamatchedcasecontrolstudyinlusakazambia